Aug 13 (Reuters)-
Chiome Bioscience Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2026 Jun 30, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 273 mln 251 mln
(+8.7 pct) (-4.5 pct)
Operating loss 479 mln loss 536 mln
Recurring loss 481 mln loss 539 mln
Net loss 483 mln loss 540 mln
EPS loss 6.62 yen loss 7.97 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Chiome Bioscience Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4583.T